{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:50:07Z","timestamp":1793663407244,"version":"4.5.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.maturitas.2014.05.019","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T16:01:09Z","timestamp":1401724869000},"page":"310-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study"],"prefix":"10.1016","volume":"78","author":[{"given":"Louise M.E.","family":"Moberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Samsioe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Borgfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.maturitas.2014.05.019_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11657-013-0137-0","article-title":"Osteoporosis in the European Union: a compendium of country-specific reports","volume":"8","author":"Svedbom","year":"2013","journal-title":"Arch Osteoporos"},{"issue":"4","key":"10.1016\/j.maturitas.2014.05.019_bib0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.05.019_bib0015","series-title":"Report of a WHO Study Group","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","volume":"vol. 843","year":"1994"},{"issue":"3","key":"10.1016\/j.maturitas.2014.05.019_bib0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jocd.2011.04.010","article-title":"Fracture burden in relation to low bone mineral density and FRAX((R)) probability","volume":"14","author":"Leslie","year":"2011","journal-title":"J Clin Densitom"},{"issue":"9321","key":"10.1016\/j.maturitas.2014.05.019_bib0025","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.maturitas.2014.05.019_bib0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-012-2112-9","article-title":"The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study","volume":"24","author":"Fraser","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.maturitas.2014.05.019_bib0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-012-2015-9","article-title":"Relationship between use of antidepressants and risk of fractures: a meta-analysis","volume":"24","author":"Rabenda","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.maturitas.2014.05.019_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2009.11.009","article-title":"The women's health in the Lund area (WHILA) study \u2013 an overview","volume":"65","author":"Samsioe","year":"2010","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2014.05.019_bib0045","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","article-title":"Meta-analysis: risk of fractures with acid-suppressing medication","volume":"48","author":"Kwok","year":"2011","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.maturitas.2014.05.019_bib0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"106","author":"Ngamruengphong","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.maturitas.2014.05.019_bib0055","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ajg.2012.200","article-title":"The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"107","author":"Targownik","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.maturitas.2014.05.019_bib0060","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00296-013-2709-0","article-title":"Bone density in proton pump inhibitors users: a prospective study","volume":"33","author":"Ozdil","year":"2013","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.maturitas.2014.05.019_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.maturitas.2009.07.006","article-title":"Proton pump inhibitors: osteoporosis, and osteoporosis-related fractures","volume":"64","author":"Fournier","year":"2009","journal-title":"Maturitas"},{"issue":"11","key":"10.1016\/j.maturitas.2014.05.019_bib0070","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1302\/0301-620X.95B11.31158","article-title":"Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study","volume":"95-B","author":"Salai","year":"2013","journal-title":"Bone Joint J"},{"issue":"2","key":"10.1016\/j.maturitas.2014.05.019_bib0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.maturitas.2014.05.019_bib0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/17453674.2012.747922","article-title":"Screening for osteoporosis reduced new fracture incidence by almost half: a 6-year follow-up of 592 fracture patients from an osteoporosis screening program","volume":"83","author":"\u00c5strand","year":"2012","journal-title":"Acta Orthop"},{"issue":"11","key":"10.1016\/j.maturitas.2014.05.019_bib0085","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jbmr.1759","article-title":"Type 2 diabetes and bone","volume":"27","author":"Leslie","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.maturitas.2014.05.019_bib0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1210\/jc.2007-0843","article-title":"The association between hyperglycemia and fracture risk in middle age. A prospective: population-based study of 22,444 men and 10,902 women","volume":"93","author":"Holmberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.maturitas.2014.05.019_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11596-013-1105-z","article-title":"Inhibitory effects of high glucose\/insulin environment on osteoclast formation and resorption in vitro","volume":"33","author":"Xu","year":"2013","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"9","key":"10.1016\/j.maturitas.2014.05.019_bib0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/dom.12077","article-title":"Antidiabetic therapy effects on bone metabolism and fracture risk","volume":"15","author":"Montagnani","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.maturitas.2014.05.019_bib0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-12-56","article-title":"Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study","volume":"12","author":"Close","year":"2012","journal-title":"BMC Gastroenterol"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:00:01Z","timestamp":1759914001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512214001832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0378512214001832"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.019","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}